Cargando…
Potent inhibition of microRNA in vivo without degradation
Chemically modified antisense oligonucleotides (ASOs) are widely used as a tool to functionalize microRNAs (miRNAs). Reduction of miRNA level after ASO inhibition is commonly reported to show efficacy. Whether this is the most relevant endpoint for measuring miRNA inhibition has not been adequately...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615630/ https://www.ncbi.nlm.nih.gov/pubmed/19015151 http://dx.doi.org/10.1093/nar/gkn904 |
_version_ | 1782163347583533056 |
---|---|
author | Davis, Scott Propp, Stephanie Freier, Susan M. Jones, Laura E. Serra, Martin J. Kinberger, Garth Bhat, Balkrishen Swayze, Eric E. Bennett, C. Frank Esau, Christine |
author_facet | Davis, Scott Propp, Stephanie Freier, Susan M. Jones, Laura E. Serra, Martin J. Kinberger, Garth Bhat, Balkrishen Swayze, Eric E. Bennett, C. Frank Esau, Christine |
author_sort | Davis, Scott |
collection | PubMed |
description | Chemically modified antisense oligonucleotides (ASOs) are widely used as a tool to functionalize microRNAs (miRNAs). Reduction of miRNA level after ASO inhibition is commonly reported to show efficacy. Whether this is the most relevant endpoint for measuring miRNA inhibition has not been adequately addressed in the field although it has important implications for evaluating miRNA targeting studies. Using a novel approach to quantitate miRNA levels in the presence of excess ASO, we have discovered that the outcome of miRNA inhibition can vary depending on the chemical modification of the ASO. Although some miRNA inhibitors cause a decrease in mature miRNA levels, we have identified a novel 2′-fluoro/2′-methoxyethyl modified ASO motif with dramatically improved in vivo potency which does not. These studies show there are multiple mechanisms of miRNA inhibition by ASOs and that evaluation of secondary endpoints is crucial for interpreting miRNA inhibition studies. |
format | Text |
id | pubmed-2615630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26156302009-03-30 Potent inhibition of microRNA in vivo without degradation Davis, Scott Propp, Stephanie Freier, Susan M. Jones, Laura E. Serra, Martin J. Kinberger, Garth Bhat, Balkrishen Swayze, Eric E. Bennett, C. Frank Esau, Christine Nucleic Acids Res RNA Chemically modified antisense oligonucleotides (ASOs) are widely used as a tool to functionalize microRNAs (miRNAs). Reduction of miRNA level after ASO inhibition is commonly reported to show efficacy. Whether this is the most relevant endpoint for measuring miRNA inhibition has not been adequately addressed in the field although it has important implications for evaluating miRNA targeting studies. Using a novel approach to quantitate miRNA levels in the presence of excess ASO, we have discovered that the outcome of miRNA inhibition can vary depending on the chemical modification of the ASO. Although some miRNA inhibitors cause a decrease in mature miRNA levels, we have identified a novel 2′-fluoro/2′-methoxyethyl modified ASO motif with dramatically improved in vivo potency which does not. These studies show there are multiple mechanisms of miRNA inhibition by ASOs and that evaluation of secondary endpoints is crucial for interpreting miRNA inhibition studies. Oxford University Press 2009-01 2008-11-16 /pmc/articles/PMC2615630/ /pubmed/19015151 http://dx.doi.org/10.1093/nar/gkn904 Text en © 2008 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RNA Davis, Scott Propp, Stephanie Freier, Susan M. Jones, Laura E. Serra, Martin J. Kinberger, Garth Bhat, Balkrishen Swayze, Eric E. Bennett, C. Frank Esau, Christine Potent inhibition of microRNA in vivo without degradation |
title | Potent inhibition of microRNA in vivo without degradation |
title_full | Potent inhibition of microRNA in vivo without degradation |
title_fullStr | Potent inhibition of microRNA in vivo without degradation |
title_full_unstemmed | Potent inhibition of microRNA in vivo without degradation |
title_short | Potent inhibition of microRNA in vivo without degradation |
title_sort | potent inhibition of microrna in vivo without degradation |
topic | RNA |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615630/ https://www.ncbi.nlm.nih.gov/pubmed/19015151 http://dx.doi.org/10.1093/nar/gkn904 |
work_keys_str_mv | AT davisscott potentinhibitionofmicrornainvivowithoutdegradation AT proppstephanie potentinhibitionofmicrornainvivowithoutdegradation AT freiersusanm potentinhibitionofmicrornainvivowithoutdegradation AT joneslaurae potentinhibitionofmicrornainvivowithoutdegradation AT serramartinj potentinhibitionofmicrornainvivowithoutdegradation AT kinbergergarth potentinhibitionofmicrornainvivowithoutdegradation AT bhatbalkrishen potentinhibitionofmicrornainvivowithoutdegradation AT swayzeerice potentinhibitionofmicrornainvivowithoutdegradation AT bennettcfrank potentinhibitionofmicrornainvivowithoutdegradation AT esauchristine potentinhibitionofmicrornainvivowithoutdegradation |